Search Results - "Chen, Chi Yi"

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial by Liou, Jyh-Ming, Chen, Chieh-Chang, Chang, Chih-Min, Fang, Yu-Jen, Bair, Ming-Jong, Chen, Po-Yueh, Chang, Chi-Yang, Hsu, Yao-Chun, Chen, Mei-Jyh, Chen, Chien-Chuan, Lee, Ji-Yuh, Yang, Tsung-Hua, Luo, Jiing-Chyuan, Chen, Chi-Yi, Hsu, Wen-Feng, Chen, Yen-Nien, Wu, Jeng-Yih, Lin, Jaw-Town, Lu, Tzu-Pin, Chuang, Eric Y, El-Omar, Emad M, Wu, Ming-Shiang

“…In first-line treatment of Helicobacter pylori, we have previously shown that the eradication frequency was 83·7% (95% CI 80·4–86·6) for triple therapy for 14…”
Get full text

Bio‐based hydroxymethylated eugenol modified bismaleimide resin and its high‐temperature composites by Ning, Yi, Li, Dian‐sen, Wang, Ming‐cun, Chen, Yi‐chi, Jiang, Lei

“…Hydroxymethylated eugenol (MEG) and poly (hydroxymethylated eugenol) (PMEG) were synthesized by the condensation reaction of eugenol (EG) with formaldehyde…”
Get full text

21st-century rise in anthropogenic nitrogen deposition on a remote coral reef by Ren, Haojia, Chen, Yi-Chi, Wang, Xingchen T., Wong, George T. F., Cohen, Anne L., DeCarlo, Thomas M., Weigand, Mira A., Mii, Horng-Sheng, Sigman, Daniel M.

“…With the rapid rise in pollution-associated nitrogen inputs to the western Pacific, it has been suggested that even the open ocean has been affected. In a…”
Get full text

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan by Liu, Chen‐Hua, Yu, Ming‐Lung, Peng, Cheng‐Yuan, Hsieh, Tsai‐Yuan, Huang, Yi‐Hsiang, Su, Wei‐Wen, Cheng, Pin‐Nan, Lin, Chih‐Lin, Lo, Ching‐Chu, Chen, Chi‐Yi, Chen, Jyh‐Jou, Ma, Qian, Brooks‐Rooney, Craig, Kao, Jia‐Horng

“…Summary Background While direct‐acting antivirals have been approved for treating hepatitis C, the guidelines highlight the importance of considering potential…”
Get full text

A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B by Yuen, Man‐Fung, Chen, Chi‐Yi, Liu, Chun‐Jen, Jeng, Wen‐Juei, Elkhashab, Magdy, Coffin, Carla S., Kim, Won, Greenbloom, Susan, Ramji, Alnoor, Lim, Young S., Kim, Yoon J., Fung, Scott K., Kim, Dong J., Jang, Jeong‐Won, Lee, Kwan Sik, Iyer, Radhakrishnan P., Macfarlane, Chelsea, Jackson, Kathy, Locarnini, Stephen A., Chan, Henry L. Y., Afdhal, Nezam H.

“…Background/Aims Novel agents acting against hepatitis B virus (HBV) are needed to improve HBsAg seroclearance or termed as ‘functional cure’. Inarigivir…”
Get full text

Phytochemical and anti-MRSA constituents of Zanthoxylum nitidum by Zeng, Qi, Wang, Zhao-Jie, Chen, Song, Wang, Huan, Xie, Tian-Zhen, Xu, Xiang-Juan, Xiang, Mei-Ling, Chen, Yi-Chi, Luo, Xiao-Dong

“…Infectious diseases caused by multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus, pose a significant threat to humanity…”
Get full text

miR‐346 and miR‐582‐3p‐regulated EG‐VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9 by Su, Mei‐Tsz, Tsai, Pei‐Yin, Tsai, Hui‐Ling, Chen, Yi‐Chi, Kuo, Pao‐Lin

“…Endocrine gland‐derived vascular endothelial growth factor (EG‐VEGF) is an important regulator for embryo implantation and placental development, and is…”
Get full text

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment by Liu, Chen-Hua, Chen, Chi-Yi, Su, Wei-Wen, Tseng, Kuo-Chih, Lo, Ching-Chu, Liu, Chun-Jen, Chen, Jyh-Jou, Peng, Cheng-Yuan, Shih, Yu-Lueng, Yang, Sheng-Shun, Huang, Chia-Sheng, Huang, Ke-Jhang, Chang, Chi-Yang, Tsai, Ming-Chang, Kao, Wei-Yu, Fang, Yo-Jen, Chen, Po-Yueh, Su, Pei-Yuan, Tseng, Chih-Wei, Huang, Jow-Jyh, Lee, Pei-Lun, Lai, Hsueh-Chou, Hsieh, Tsai-Yuan, Chang, Chung-Hsin, Huang, Yi-Jie, Lee, Fu-Jen, Chang, Chun-Chao, Kao, Jia-Horng

“…Data regarding the real-world effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) with or without low-dose ribavirin (RBV) in patients with chronic…”
Get more information

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial by Hsu, Yao-Chun, Chen, Chi-Yi, Chang, I-Wei, Chang, Chi-Yang, Wu, Chun-Ying, Lee, Teng-Yu, Wu, Ming-Shiang, Bair, Ming-Jong, Chen, Jyh-Jou, Chen, Chieh-Chang, Tseng, Cheng-Hao, Tai, Chi-Ming, Huang, Yen-Tsung, Ku, Wen-Hui, Mo, Lein-Ray, Lin, Jaw-Town

“…Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally raised alanine aminotransferase (ALT) is controversial. We aimed to…”
Get full text

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV by Tseng, Chih-Wei, Liu, Wen-Chun, Chen, Chi-Yi, Chang, Ting-Tsung, Tseng, Kuo-Chih

“…Hepatitis B virus (HBV) biomarkers reflect the status of HBV infection; however, their role in patients with chronic hepatitis B and C (HBV/HCV) coinfection…”
Get full text

Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks by Fung, Scott K., Pan, Calvin Q., Wong, Grace Lai‐Hung, Seto, Wai‐Kay, Ahn, Sang Hoon, Chen, Chi‐Yi, Hann, Hie‐Won L., Jablkowski, Maciej S., Kim, Yoon Jun, Yurdaydin, Cihan, Peng, Cheng‐Yuan, Nguyen, Tuan, Yatsuhashi, Hiroshi, Flaherty, John F., Yee, Leland J., Abramov, Frida, Wang, Hongyuan, Abdurakhmanov, Dzhamal, Lim, Young‐Suk, Buti, Maria

“…Summary Background Patients with chronic hepatitis B (CHB) who switch from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) show changes in…”
Get full text

Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals by Liu, Chen‐Hua, Chang, Yu‐Ping, Lee, Ji‐Yuh, Chen, Chi‐Yi, Kao, Wei‐Yu, Lin, Chih‐Lin, Yang, Sheng‐Shun, Shih, Yu‐Lueng, Peng, Cheng‐Yuan, Lee, Fu‐Jen, Tsai, Ming‐Chang, Huang, Shang‐Chin, Su, Tung‐Hung, Tseng, Tai‐Chung, Liu, Chun‐Jen, Chen, Pei‐Jer, Kao, Jia‐Horng

“…Early confirmation of sustained virologic response (SVR) or viral relapse after direct‐acting antivirals (DAAs) for hepatitis C virus (HCV) infection is…”
Get full text

Obliquity pacing of the western Pacific Intertropical Convergence Zone over the past 282,000 years by Liu, Yi, Lo, Li, Shi, Zhengguo, Wei, Kuo-Yen, Chou, Chien-Ju, Chen, Yi-Chi, Chuang, Chih-Kai, Wu, Chung-Che, Mii, Horng-Sheng, Peng, Zicheng, Amakawa, Hiroshi, Burr, George S., Lee, Shih-Yu, DeLong, Kristine L., Elderfield, Henry, Shen, Chuan-Chou

“…The Intertropical Convergence Zone (ITCZ) encompasses the heaviest rain belt on the Earth. Few direct long-term records, especially in the Pacific, limit our…”
Get full text

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan by Lin, Chih‐Lin, Tai, Chi‐Ming, Huang, Jee‐Fu, Liu, Chun‐Jen, Chen, Hui‐Fen, Cheng, Pin‐Nan, Chen, Chi‐Yi, Peng, Cheng‐Yuan, Wang, Chia‐Chi, Weng, Shih‐Han, Tseng, Tai‐Chung, Kao, Jia‐Horng

“…Background and Aim The aim of this study was to assess the impact of body mass index (BMI) on the clinical and histological characteristics of patients with…”
Get full text

Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study by Kao, Jia‐Horng, Yu, Min‐Lung, Chen, Chi‐Yi, Peng, Cheng‐Yuan, Chen, Ming‐Yao, Tang, Huoling, Chen, Qiaoqiao, Wu, Jinzi J

“…Background and Aim The need for all‐oral hepatitis C virus (HCV) treatments with higher response rates, improved tolerability, and lower pill burden compared…”
Get full text

Source apportionment and evolution of N-containing aerosols at a rural cloud forest in Taiwan by isotope analysis by Chen, Ting-Yu, Chen, Chia-Li, Chen, Yi-Chi, Chou, Charles C.-K, Ren, Haojia, Hung, Hui-Ming

“…Ammonium and nitrate are major N-containing aerosol components. The deposition of N-containing aerosols has impacts on regional ecology and the biogeochemical…”
Get full text

Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection by Tseng, Chih‐Wei, Wu, Shu‐Fen, Chen, Chi‐Yi, Ho, Yun‐Che, He, Yi‐Ting, Tseng, Kuo‐Chih

“…Regulatory T cells (Tregs) affect the pathogenesis and disease progression of chronic viral hepatitis. This study evaluated the frequency and function of Tregs…”
Get full text

A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment by Lo, Ching-Chu, Chuang, Wan-Long, Kuo, Hsing-Tao, Chen, Wei-Ming, Qin, Albert, Tsai, Chan-Yen, Huang, Yi-Wen, Chen, Chi-Yi

“…Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. Its biweekly dosing schema has demonstrated tolerability and clinical efficacy for…”
Get full text

Nonlinear climatic sensitivity to greenhouse gases over past 4 glacial/interglacial cycles by Lo, Li, Chang, Sheng-Pu, Wei, Kuo-Yen, Lee, Shih-Yu, Ou, Tsong-Hua, Chen, Yi-Chi, Chuang, Chih-Kai, Mii, Horng-Sheng, Burr, George S., Chen, Min-Te, Tung, Ying-Hung, Tsai, Meng-Chieh, Hodell, David A., Shen, Chuan-Chou

“…The paleoclimatic sensitivity to atmospheric greenhouse gases (GHGs) has recently been suggested to be nonlinear, however a GHG threshold value associated with…”
Get full text

Efficacy and Safety of Exploring Deeper Sections of the Infrapapillary Area of the Duodenum by Using Sedative Esophagogastroduodenoscopy by Hsu, Ming-Tse, Chen, Chi-Yi, Liao, Kai-Sheng, Chung, Wei-Sheng

“…Background. Using conventional esophagogastroduodenoscopy (EGD) to evaluate the infrapapillary area is not feasible. The use of sedative EGD may enable…”
Get full text